Yousif Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Yousif Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$867K	Buy	34,265 +231	+0.7%	+$5.08K	0.01%	1127
2026 Q1	$758K	Sell	34,034 -325	-0.9%	-$7.77K	0.01%	1207
2025 Q4	$903K	Sell	34,359 -4,952	-13%	-$118K	0.01%	1132
2025 Q3	$839K	Sell	39,311 -7,462	-16%	-$176K	0.01%	1193
2025 Q2	$1.01M	Buy	46,773 +790	+2%	+$14.7K	0.01%	1115
2025 Q1	$764K	Buy	+45,983	New	+$835K	0.01%	1239

Other funds holding ACAD

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Yousif Capital Management's ACAD Position: Q2 2026 in Review

Yousif Capital Management increased its Acadia Pharmaceuticals (ACAD) stake by 0.68% in Q2 2026, buying an estimated $5.08K and bringing the position to 34,265 shares worth $867K. The position accounts for 0.01% of the portfolio, ranked #1127.

Yousif Capital Management first reported a position in ACAD in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.01M in Q2 2025. 53 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

Yousif Capital Management held 34,265 shares of Acadia Pharmaceuticals worth $867K as of Q2 2026.
Yousif Capital Management bought 231 Acadia Pharmaceuticals shares in Q2 2026, an estimated $5.08K.
Acadia Pharmaceuticals made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1127 holding.
Yousif Capital Management first reported a position in Acadia Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Yousif Capital Management's Acadia Pharmaceuticals position peaked at $1.01M in Q2 2025.
53 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.